Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
Antibody–drug conjugates (ADCs) and immune checkpoint inhibitors (ICIs) have reshaped cancer therapy both as monotherapy and in combination. However, these drug classes have toxicity profiles...















